Cancer Genomics
Pioneer the path to precision genomics
With over 25 years of experience serving the cancer research community, we are focused on developing the right products, services, and support to meet the unique challenges of cancer genomics research.
With access to these innovative products and platforms, you can uncover the genetic variants and RNA signatures you need to power your next breakthrough.
Targeted NGS assays for cancer research
Explore Oncomine assays and Ion AmpliSeq technology and panels.
Cancer RNA expression
Uncover RNA signatures that provide new insights in the identification, characterization, and progression of cancer subtypes.
Ion AmpliSeq technology
Simple and fast library construction for affordable targeted sequencing.
Cancer genotyping assays: somatic and germline
Accurately screen or confirm somatic and germline variants of choice using sequencing and real-time PCR.
Targeted NGS solutions for oncology research
Focus your cancer research with end-to-end targeted sequencing solutions including sample to analysis and report for solid tumor samples, immuno-oncology, and more.
Cancer epigenetics
Identify epigenetic changes that occur during tumor progression.
Liquid biopsy research
Detect new biomarkers and develop future tests from NGS analyses of cell-free DNA (cfDNA) in serially collected whole-blood research samples.
Whole exome sequencing
Discover new biomarkers for cancer research using exome sequencing.
Laser capture microdissection
Isolate pure populations of cancer cells from tumor tissues.
Copy number analysis with microarrays
Microarrays are the platform of choice for detecting DNA structural variants (SV) such as chromosome insertions, duplications, and deletions.
